[Assessment of the structural and functional state of blood vessels in patients with hypertrophic cardiomyopathy]. 2021

F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow.

Aim      To evaluate the structural and functional condition of the vasculature using fingertip photoplethysmography and computerized videocapillaroscopy in patients with hypertrophic cardiomyopathy (HCMP).Material and methods  The study included patients with HCMP (n=48; 28 (57 %) men; age, 54.3±13.6 years) and healthy volunteers (control group, n=33, 15 (45 %) men; age, 58.2±8.8 years). Standard laboratory and instrumental examination (blood count and biochemistry, electrocardiography, echocardiography, Holter electrocardiogram monitoring) were performed for all HCMP patients. The condition of vascular wall at various levels of the vasculature was evaluated by fingertip photoplethysmography (apparatus Angioscan-01) and computerized nail-fold videocapillaroscopy (apparatus Capillaroscan-01). The photoplethysmography study analyzed structural parameters, including the arterial wall stiffness index (aSI) of large blood vessels and the resistance index (RI) of small muscular arteries. Endothelial dysfunction was evaluated by the occlusion index (OI) and phase shift (PS). The capillaroscopy study assessed structural parameters, including the resting capillary density (rCD) and the capillary density following venous occlusion (voCD), and functional parameters, including the percentage of perfused capillaries (PPC), the percentage of restored capillaries (PRC), and the capillary density after the reactive hyperemia test (rhCD).Results The study showed increases in aSI (8.8 [6.8; 12.2] and RI (32.5 [17.4; 47.9] in the HCMP group. The OI was significantly lower in the HCMP group (1.3 [1.1; 1.5]) than in the control group (1.8 [1.5; 2.7], р<0.001). Also, PS values were significantly decreased in the HCMP group (4.4 [2.3; 8.6]) compared to the control group (8.4 [5.1; 12.1]. p=0.018). Disorders of structural and functional capillary indexes were observed in HCMP patients compared to the control group; rCD and voCD were decreased in the HCMP group (60 [52.6; 68] and 88 [75; 90], respectively) compared to the control group (75.8 [60; 87] and 90 [73; 101]), however, no intergroup difference reached a statistical significance. The rhCD, PPC, and PRC values were decreased in the HCMP group (66.3 [55; 72], 86.7 [70.9; 104.2] and 1.7 [-6.95; 20.3], respectively) compared to the control group (86 [68.6; 100], 103 [96; 114] and 18.4 [8.1; 27.4], respectively); PPC and PRC values were significantly different (р<0.005 and p<0.004, respectively).Conclusion      In patients with HCMP, fingertip photoplethysmography and computerized videocapillaroscopy showed increased wall stiffness in both large blood vessels and microvasculature, pronounced endothelial dysfunction, and decreases in capillary density and percentage of restored capillaries following respective tests.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D020678 Microscopic Angioscopy The noninvasive microscopic examination of the microcirculation, commonly done in the nailbed or conjunctiva. In addition to the capillaries themselves, observations can be made of passing blood cells or intravenously injected substances. This is not the same as endoscopic examination of blood vessels (ANGIOSCOPY). Capillaroscopy,Nailfold Capillaroscopy,Videocapillaroscopy,Angioscopies, Microscopic,Angioscopy, Microscopic,Capillaroscopies,Capillaroscopies, Nailfold,Capillaroscopy, Nailfold,Microscopic Angioscopies,Nailfold Capillaroscopies,Videocapillaroscopies

Related Publications

F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
September 2003, Revista espanola de cardiologia,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
January 2017, Journal of computer assisted tomography,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
April 1998, Clinical science (London, England : 1979),
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
December 1982, Vrachebnoe delo,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
November 1997, Circulation,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
September 1989, Kardiologiia,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
January 1980, Terapevticheskii arkhiv,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
January 1990, Heart and vessels,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
December 2022, European heart journal. Quality of care & clinical outcomes,
F M Bogatyreva, and V Ra Yu Kaplunova, and M V Kozhevnikova, and G A Shakaryants, and N V Khabarova, and E V Privalova, and Yu N Belenkov
September 1989, Journal of the American College of Cardiology,
Copied contents to your clipboard!